These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7882031)

  • 21. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
    Chan CK; Sannajust F; Head GA
    J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Site and receptors involved in the sympathoinhibitory actions of rilmenidine.
    Head GA; Burke SL; Chan CK
    J Hypertens Suppl; 1998 Aug; 16(3):S7-12. PubMed ID: 9747904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethanol counteraction of I1-imidazoline but not alpha-2 adrenergic receptor-mediated reduction in vascular resistance in conscious spontaneously hypertensive rats.
    El-Mas MM; Abdel-Rahman AA
    J Pharmacol Exp Ther; 1999 Feb; 288(2):455-62. PubMed ID: 9918545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central cardiovascular effects of rilmenidine and neuropeptide Y in the conscious spontaneously hypertensive rat: haemodynamic and biochemical evidence for a negative interaction.
    McAuley MA; Reid JL; Macrae IM
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):945-52. PubMed ID: 1376817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. I1 imidazoline receptors in cardiovascular regulation: the place of rilmenidine.
    Head GA; Burke SL
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):89S-98S. PubMed ID: 10921527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment with quinpirole inhibits the central antihypertensive effects of rilmenidine and alpha-methyldopa in conscious rats.
    Van den Buuse M
    Eur J Pharmacol; 1997 Mar; 322(2-3):191-9. PubMed ID: 9098687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinctive features of rilmenidine possibly related to its selectivity for imidazoline receptors.
    Harron DW
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):91S-98S. PubMed ID: 1350732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in local cerebral glucose utilization during hemorrhagic hypotension in the rat.
    Savaki HE; Macpherson H; McCulloch J
    Circ Res; 1982 May; 50(5):633-44. PubMed ID: 7074727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic treatment with rilmenidine in spontaneously hypertensive rats: differences between two schedules of administration.
    Monassier L; Greney H; Thomas L; Bousquet P
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):394-401. PubMed ID: 15076223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the sympathoinhibitory effect of rilmenidine mediated by alpha-2 adrenoceptors or imidazoline receptors?
    Urban R; Szabo B; Starke K
    J Pharmacol Exp Ther; 1994 Aug; 270(2):572-8. PubMed ID: 7915315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex.
    Szabo B; Fritz T; Wedzony K
    Br J Pharmacol; 2001 Sep; 134(2):295-304. PubMed ID: 11564647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central actions of agmatine in conscious spontaneously hypertensive rats.
    Briaud S; Zhang BL; Sannajust F
    Clin Exp Hypertens; 2005 Nov; 27(8):619-27. PubMed ID: 16303638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit.
    Feldman J; Tibiriça E; Bricca G; Dontenwill M; Belcourt A; Bousquet P
    Br J Pharmacol; 1990 Jul; 100(3):600-4. PubMed ID: 2390682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment with the dopamine agonist quinpirole inhibits central antihypertensive mechanisms in rats.
    van den Buuse M; Tritton SB
    Clin Exp Pharmacol Physiol; 1997; 24(9-10):661-6. PubMed ID: 9315366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of locus coeruleus lesions upon metabolic activity in CNS nuclei involved in cardiovascular regulation.
    Savaki HE; Graham DI; McCulloch J
    Brain Res; 1983 Jul; 271(1):109-14. PubMed ID: 6883109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat.
    Sharkey J; Ritchie IM; Butcher SP; Kelly JS
    Brain Res; 1994 Jul; 651(1-2):27-36. PubMed ID: 7922575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of sinoaortic barodenervation on the hypotensive effects of imidazoline-like drugs in stroke-prone spontaneously hypertensive rats.
    Medvedev OS; Kunduzova OR; Murashev AN; Medvedeva NA
    Ann N Y Acad Sci; 1999 Jun; 881():295-9. PubMed ID: 10415929
    [No Abstract]   [Full Text] [Related]  

  • 38. Mitogen-activated protein kinase phosphorylation in the rostral ventrolateral medulla plays a key role in imidazoline (i1)-receptor-mediated hypotension.
    Zhang J; Abdel-Rahman AA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):945-52. PubMed ID: 15901801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current data on the pharmacology of rilmenidine].
    Montastruc JL; Macquin-Mavier I; Damase-Michel C; Dard B; Tran MA; Valet P
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():25-9. PubMed ID: 2517006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
    Prichard BN; Graham BR
    Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.